Table 4 Comparison of paraclinical characteristics in thalassemic patients with and without SENV infection.
From: High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran
| Â | SENV | SENV-D | SENV-H | Co-infection(+) | |||
|---|---|---|---|---|---|---|---|
Characteristics | + (N = 98) | - (N = 2) | + (N = 86) | - (N = 14) | + (N = 93) | - (N = 7) | (N = 81) |
Gender [male (%)] | 48 (49%) | 1 (50%) | 41 (47%) | 8 (57%) | 46 (49%) | 3 (42%) | 39 (48%) |
Age (years) | 22.4 ± 6.2 | 20.5 ± 2.1 | 22.2 ± 5.5 | 23.8 ± 9.3 | 22.4 ± 6.3 | 22.6 ± 4.0 | 22.1 ± 5.5 |
WBC count (× 103) | 14.9 ± 15.9 | 7.7 ± 2.7 | 14.7 ± 14.7 | 15.0 ± 21.9 | 14.1 ± 15.1 | 23.8 ± 23.0 | 13.8 ± 13.6 |
Platelet count (× 104) | 43.9 ± 25.5 | 32.8 ± 18.1 | 45.3 ± 26.2 | 33.7 ± 16.2 | 43.6 ± 25.6 | 44.2 ± 23.0 | 45.1 ± 26.4 |
MCH (pg) | 26.1 ± 1.4 | 24.7 ± 1.1 | 26.212 ± 1.390†| 25.321 ± 1.632 | 26.1 ± 1.5 | 25.9 ± 1.5 | 26.201 ± 1.394‡ |
ALT (IU/L) | 26.0 ± 19.1 | 13.5 ± 14.2 | 26.7 ± 19.2 | 18.1 ± 17.8 | 25.7 ± 19.1 | 22.9 ± 21.9 | 26.5 ± 19.2 |
AST (IU/L) | 27.7 ± 18.7 | 21.4 ± 13.0 | 27.6 ± 18.5 | 27.8 ± 19.5 | 27.7 ± 18.9 | 26.1 ± 15.0 | 27.5 ± 18.7 |